La’Ron Browne: Balancing Clinical Benefits and Healthcare Costs in Hydroxyurea Management of SCD in Brazil
La’Ron Browne, Instructor at St. Jude Children’s Research Hospital, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Global Hematology, adding:
”I am pleased to announce that our paper on Hydroxyurea therapy in Sickle Cell Disease (SCD): Evaluating healthcare costs and use in a Brazilian tertiary setting has been shortlisted by Blood Global Hematology for impactful manuscripts.
In our study, we highlight that while hydroxyurea (HU) decreased acute utilization in patients with SCD, it did not reduce overall healthcare costs.
The likely drivers of the total health costs were persistent chronic care management, decreased adherence, and later initiation of hydroxyurea.
These findings are important for many low- and middle-income countries (LMIC) and upper-middle-income countries (UMIC) to initiate conversations about implementing hydroxyurea early in life, which can help mitigate the long-standing costs associated with chronic diseases like SCD.”
Title: Hydroxyurea therapy in sickle cell disease: evaluating health care costs and use in a Brazilian tertiary setting
Authors: La’Ron L. A. Browne, Emilia Matos do Nascimento, Patricia Moura, Delaine Fidlarczyk, Jane Duran, Roberto Barbosa, Thais Oliveira, George Goshua, Jane S. Hankins, Clarisse Lobo

Stay updated on all scientific advances with Hemostasis Today.
-
May 31, 2026, 10:09Purusotham Chippala: A 47-Year-Old Stroke Survivor Taught Me Something Modern Healthcare Keeps Ignoring
-
May 31, 2026, 10:03Mohammed Sakib Hasan: We Propose Innovative AI-Driven Solutions for Real-Time Stroke Prediction
-
May 31, 2026, 09:49Ermias Solomon Yalew: New Insights Into Multimorbidity and Disability After Stroke from Ethiopia
-
May 31, 2026, 07:02Raising Awareness of Cerebral Venous Sinus Thrombosis in Women – NBCA
-
May 31, 2026, 07:00Ceri Roberts: How to Reduce Your Risk of a Blood Clot
-
May 31, 2026, 05:28Nikolaos Androulakis: Inflammatory Burden and Antiphospholipid Antibodies in Lupus Anticoagulant Testing
-
May 31, 2026, 05:28Alysha Arif: Understanding a Complex Case of Postpartum Seizures
-
May 31, 2026, 05:27Chiara Novelli: Are We Validating Laboratory Algorithms as Rigorously as We Validate Laboratory Tests?
-
May 31, 2026, 02:42Katja van den Hurk: Optimizing Iron Management in Blood Donors